在酒精性肝损伤中,ASPP2缺乏减弱了通过PPARγ通路的脂质积累
Ying Zhang1, Xingzhong Miao1, Fang Liu2
1Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, China.
p53的亡刺激蛋白2 (ASPP2) 通过上调PPARγ通路来加剧酒精性肝病 (ALD),促进脂质积累和肝损伤. 减少ASPP2可以减轻这些酒精诱导的影响.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 酒精性肝病 (ALD) 始于肝硬化症.
- 在非酒精性脂肪性肝病 (NAFLD) 中,p53的亡刺激蛋白2 (ASPP2) 可能会影响脂质代谢.
- 在酒精诱导的肝脂积累中ASPP2的作用尚未完全理解.
研究的目的:
- 调查ASPP2在酒精诱导的肝脂积累和肝损伤中的作用.
- 阐明涉及ALD中ASPP2的潜在机制.
- 检查ASPP2和氧酶增殖器激活受体玛 (PPARγ) 在ALD中的信号传导之间的关系.
主要方法:
- 建立了体内和体外酒精性肝损伤模型.
- 分析了来自ALD患者的临床肝脏组织.
- 通过HE染色,油红色O染色和qPCR评估脂质代谢.
- 评估了ASPP2和PPARγ信号通路,使用西方涂抹和免疫组织化学染色.
主要成果:
- 在ALD患者和小鼠模型中,ASPP2和PPARγ表达升高.
- 下调ASPP2显著降低了PPARγ的表达,缓解了酒精诱导的肝脂积累和肝损伤.
- PPARγ激动剂逆转了ASPP2降低的保护作用,而抑制剂显示了相反的结果.
结论:
- 在ALD中,ASPP2促进乙醇诱导的脂质积累和肝损伤.
- ASPP2通过调节PPARγ信号通路来加剧ALD.
- 针对ASPP2可能为ALD提供治疗策略.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Cirrhosis II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology
